Literature DB >> 19854647

Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo.

Richard W A Luke1, Peter Ballard, David Buttar, Leonie Campbell, Jon Curwen, Steve C Emery, Alison M Griffen, Lorraine Hassall, Barry R Hayter, Cliff D Jones, William McCoull, Martine Mellor, Mike L Swain, Julie A Tucker.   

Abstract

The SAR and improvement in potency against Tie2 of novel thienopyrimidine and thiazolopyrimidine kinase inhibitors are reported. The crystal structure of one of these compounds bound to the Tie-2 kinase domain is consistent with the SAR. These compounds have moderate potency in cellular assays of Tie-2 inhibition, good physical properties, DMPK, and show evidence of in vivo inhibition of Tie-2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854647     DOI: 10.1016/j.bmcl.2009.10.001

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers.

Authors:  Rana M Abdelnaby; Afaf A El-Malah; Rasha R FakhrEldeen; Marwa M Saeed; Rania I Nadeem; Nancy S Younis; Hanaa M Abdel-Rahman; Nehad M El-Dydamony
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-02

2.  Design, Cytotoxicity and Antiproliferative Activity of 4-Amino-5-methyl-thieno[2,3-d]pyrimidine-6-carboxylates against MFC-7 and MDA-MB-231 Breast Cancer Cell Lines.

Authors:  Anelia Mavrova; Stephan Dimov; Inna Sulikovska; Denitsa Yancheva; Ivan Iliev; Iana Tsoneva; Galya Staneva; Biliana Nikolova
Journal:  Molecules       Date:  2022-05-21       Impact factor: 4.927

3.  Effect of novel synthetic evodiamine analogue on sexual behavior in male rats.

Authors:  Neeraj S Vyawahare; Avinash A Hadambar; Aparna S Chothe; Rajeshwar R Jalnapurkar; Amol M Bhandare; Muthu K Kathiravan
Journal:  J Chem Biol       Date:  2011-10-04

4.  In Silico Exploration for Novel Type-I Inhibitors of Tie-2/TEK: The Performance of Different Selection Strategy in Selecting Virtual Screening Candidates.

Authors:  Peichen Pan; Huiyong Sun; Hui Liu; Dan Li; Wenfang Zhou; Xiaotian Kong; Youyong Li; Huidong Yu; Tingjun Hou
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

5.  Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.

Authors:  Tomer Shlamkovich; Lidan Aharon; William A Barton; Niv Papo
Journal:  Oncotarget       Date:  2017-05-16

6.  Targeting the Tie2-αvβ3 integrin axis with bi-specific reagents for the inhibition of angiogenesis.

Authors:  Tomer Shlamkovich; Lidan Aharon; Dana Koslawsky; Yulia Einav; Niv Papo
Journal:  BMC Biol       Date:  2018-08-17       Impact factor: 7.431

7.  Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.

Authors:  Hassan Y Ebrahim; Khalid A El Sayed
Journal:  Mar Drugs       Date:  2016-03-11       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.